References
- Nakhooda A F, Like A A, Chappel C I, Murray F T, Marliss E B. The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 1977; 26: 100–112
- The Juvenile Diabetes Foundation workshop on the spontaneously diabetic BB rat: Its potential for insight into human juvenile diabetes. Banff, Alberta, Canada, September 8–10, 1982. Metabolism 1983; 7(Suppl 1)1–166
- Seemayer T A, Tannenbaum G S, Goldman H, Colle E. Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light microscopy and ultrastructural observations of pancreatic islets of Langerhans. Am J Path 1982; 106: 237–249
- Dyrberg T, Nakhooda A F, Baekkeskov S, Lernmark Poussier A P, Marliss E B. Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes 1982; 31: 278–81
- Markholst H, Lernmark Å. Reduced pancreatic insulin is associated with retarded growth of the pancreas in young pre-diabetic BB rats. Pancreas 1988; 3: 140–144
- Like A A, Biron C A, Weringer E J, Byman K, Sroczynski E, Guberski D L. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T-lymphocytes or natural killer cells. J Exp Med 1986; 164: 1145–59
- Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB rats. Diabetes 1985; 34: 197–99
- Lee K U, Kim M K, Amano K, Pak C Y, Jaworski M A, Metha J G, Yoon J-W. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes 1988; 37: 1053–58
- Braquet P, Touqui L, Shen T Y, Vargaftig B B. Perspectives in platelet-activating factor research. Pharmacol Rev 1987; 39: 97–145
- Braquet P. The ginkgolides: potent platelet-activating factor antagonists isolated from Ginkgo Biloba L: Chemistry, pharmacology and clinical applications. Drugs of the Future 1987; 2: 643–699
- Voelkel N F, Worthen S, Reeves J T, Henson P M, Murphy R C. Nonimmunological production of leukotrienes induced by platelet-activating factor. Science 1982; 218: 286–288
- Tamura N, Agrawal D K, Townley R G, Braquet P. Platelet-activating factor, human eosinophils and ginkgolide B (BN 52021). Ginkgolides - Chemistry, Biology, Pharmacology, and Clinical Perspective, P Braquet. Prous Science Publication, BarcelonaSpain 1988; 217–224
- Braquet P, Rola-Plesczynski M. Platelet-activating factor and cellular immune responses. Immunol Today 1987; 8: 345–352
- Lachachi H, Plantavid M, Simon M F, Chap H, Braquet P, Bla-Zyl D. Inhibition of transmembrane movement and metabolism of Platelet-activating factor (PAF-acether) by a specific antagonist, BN 52021. Biochem Biophys Res Commun 1985; 132: 450–466
- Hernando P, Egido J, Gonzalez J, Pirotzky E, Hosford D, Braquet P. The effect of platelet-activating factor antagonist Ginkgolide, BN 52021, on hepatic glycogenosis and alloxan-dia-betes in rats. Ginkgolides - Chemistry, Biology, Pharmacology, and Clinical Perspective, P Braquet. Prous Science Publication, BarcelonaSpain 1988; 519–527
- Farkas G, Mandi Y, Koltai M, Braquet P. Graft protective effect of BN 52021, a specific PAF-acether antagonist in an in vitro langerhans islet-splenic lymphocyte model. Ginkgolides - Chemistry, Biology, Pharmacology, and Clinical Perspective, P Braquet. Prous Science Publication, BarcelonaSpain 1988; 737–741
- Manual of Histological Staining Methods of the Armed Forces Institute of Pathology. Third edition, L G Luna. McGraw-Hill, New York 1960
- Graham R C, Karnovsky M J. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 1966; 14: 291–302
- Ott L. An Introduction to Statistical Methods and Data Analysis. Second Edition. Duxbury Press, Boston
- Becker R A, Chambers J M, Wilks A R. The New S Language. Wadsworth and Brooks/Cole, Pacific Groove, CA 1988
- Dyrberg T, Poussier P, Nakhooda F, Marliss E B, Lernmark Å. Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia 1984; 26: 159–165
- Baekkeskov S, Dyrberg T, Lernmark Å. Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 1984; 224: 1348–1350
- Svenningsen A, Dyrberg T, Markholst H, Binder C, Lernmark Å. Insulin release and pancreatic insulin is reduced in young prediabetic BB rats. Acta Endocrinol 1986; 112: 367–371
- Lohr M, Markholst H, Dyrberg T, Klppel G, Oberholzer M, Lernmark Å. Insulitis and diabetes are preceded by a decrease in β cell volume in diabetes-prone BB rats. Pancreas 1989; 4: 95–100
- Walker R, Bone A J, Cooke A, Baird J D. Distinct macrophage subpopulations in pancreas of prediabetic BB/E rats: possible role of macrophages in pathogenesis of IDDM. Diabetes 1988; 37: 1301–1304
- Logothetopoluos J, Valiquette N, Madura E, Cvet D. The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic young adult BB rat studied by pancreatic biopsy. Diabetes 1984; 33: 33–36
- Voorbij H AM, Jeucken P HM, Kabel P J, Meeny M E, Drexhage H A. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 1989; 38: 1623–1629
- Nakhooda A F, Like A A, Chappel C I, Wei C-N, Marliss E B. The spontaneously diabetic Wistar rat (the ‘BB’ rat). Studies prior to and during development of the overt syndrome. Dia-betologia 1978; 14: 199–207
- Komiya I, Baetens D, Inman L, Perrelet A, Orci L, Unger R H. Morphometric and functional studies of islets in diabetes-prone BB/W rats that are discordant for overt diabetes. Diab Nutr Metab 1989; 2: 263–267
- Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619–633
- Doniach I, Morgan A G. Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol 1973; 2: 233–248
- Colle E, Ono S J, Fuks A, Guttmann R D, Seemayer T A. Association of susceptibility of spontaneous diabetes in rat with genes of major histocompatibility complex. Diabetes 1988; 37: 1438–1443
- Wardlaw A J, Moqbel R, Cromwell O, Kay A B. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78: 1701–1706
- Kurihara K, Wardlaw A J, Moqbel R, Kay A B. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by specific ginkgolide-derived PAF antagonist, BN 52021. J Allergy Clin Immunol 1989; 83: 83–90
- Prowse S J, Bellgrau D, Lafferty K J. Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes 1986; 35: 110–114
- Markholst H, Eastman S, Wilson D, Lernmark A. Eosinophilia, monocytosis and neutrophilia at the time of clinical onset of diabetes in BB rats. Diabetes 1989; 38(Suppl. 2)191A, (Abstr.)
- Kiirner T, Burkart V, Kolb H. Large increase of cyto-toxic/suppressor T-lymphoblasts and eosinophils around manifestation of diabetes in BB rats. Diabetes Res 1986; 3: 349–353
- Lacy P E, Wright P H. Allergic interstitial pancreatitis in rats injected with guinea pig anti-insulin serum. Diabetes 1965; 14: 634–642
- Farkas G, Mandi Y, Koltai N, Braquet P. Role of PAF in splenic lymphocyte-mediated induced impairment of Langerhans' islets. Platelet-Activating Factor and Cell Immunology - New Trends Lipid Mediators Res. Karger, Basel 1988; 85–88
- Like A A, Rossini A A, Appel M C, Guberski D L, Williams R M. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 1979; 206: 1421–1423
- Drash A L, Rudert W A, Borauaye S, Wang R, Lieberman I. Effect of probucol on development of diabetes mellitus in BB rats. Am J Cardiol 1988; 62: 27B–30B
- Dyrberg T, Schwimmbeck P L, Oldstone M BA. Inhibition of diabetes in BB rats by virus infection. J Clin Invest 1988; 81: 928–931
- Satoh J, Shintani S, Oya K, Tanaka S-I, Nobunaga T, Toyota Y, Goto Y. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 1988; 37: 1188–1194
- Jaworski M A, Jewell L D, Honore L, Mehta J G, Bayens-Simmonds J, McGuire-Clark P, Schouls J J, Yap W Y. Immunosuppression in autoimmune disease: The double-edged sword. Clin Invest Med 1987; 10: 488–495
- Rossini A A, Slavin S, Woda B A, Geisberg M, Like A A, Mordes J P. Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes 1984; 33: 543–547
- Laupacis A, Stiller C R, Gardell C, Keown P, Dupre J, Wallace A C, Thibert P. Cyclosporin prevents diabetes in BB Wistar ms. Lancet 1983; i: 10–12
- Rossini A A, Mordes J P, Pelletier A M, Like A A. Transfusions of whole blood prevents spontaneous diabetes mellitus in the BB/W rat. Science 1983; 219: 975–977
- Like A A, Kislauskis E, Williams R M, Rossini A A. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science 1982; 216: 644–646
- Naji A, Silvers W K, Bellgrau D, Anderson A O, Plotkin S, Barker C F. Prevention of diabetes in rats by bone marrow transplantation. Ann Surg 1981; 194: 328–338
- Pipeleers D, van de Winkel M, Dyrberg T, Lernmark Å. Spontaneously diabetic BB rats have age-dependent islet β-cell-specific surface antibodies at clinical onset. Diabetes 1987; 36: 1111–1115
- Wilson C A, Jacobs C, Baker P, Baskin D G, Dower S, Lernmark Å, Toivola B, Vertrees S, Wilson D. IL-l β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990; 144: 3784–3788